Benchling

On a mission to unlock the power of biotechnology and empower our global customers to get to milestones & market faster.

Founded 2012

San Francisco, United States 813 employees Series F+ Total: $411.13M Biotechnology, Life Sciences

General Information

Company Name Benchling

Founded Year 2012

Location

San Francisco, United States

Founders / Decision Makers

Employees 813

Industries Biotechnology, Life Sciences

Funding Stage Series F+

Business Model B2B, SaaS, Platform

Revenue Model Subscription, Usage Based, Service Fee

Hiring 34 roles posted in the month to 7 Nov 2026

Offices as of Nov 2026

San Francisco, United States Boston, United States Zurich, Switzerland Belfast, United Kingdom

Social

BounceWatch is an independent company data service, not affiliated with Benchling. To contact Benchling, visit benchling.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Benchling compare?

A PDF of Benchling and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Benchling soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

From the desk

Is Benchling on your competitive set?

Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.

Book a 7-day Readout

Discover More

United States Market

Market Signals All Companies

Biotechnology

Industry Signals All Companies in United States

Benchling Alternatives

All Signals Trend Reports

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Actively Hiring Nov 06, 2026

Hiring for 34 positions in the last 30 days.

Product Launch Nov 06, 2026

Benchling announced BenchBench-Refusals, a new benchmark to test frontier LLMs on biology request refusals.

Event Participation Nov 04, 2026

Benchling experts are taking the stage at #Benchtalk Europe to discuss AI agents, lab automation, and R&D apps.

Feature Release Nov 03, 2026

Benchling launched memory in Benchling AI, allowing agents to retain best practices, decisions, and context from previous runs.

In The News Oct 30, 2026

Featured on Tracxn: Benchling - 2026 Funding Rounds & List of Investors

Tech Stack Change Oct 30, 2026

Added Amplitude to their site.

+4 more signals in last 30 days

Benchling a competitor of yours? Have our desk watch it

AI Insight

Bounce Watch AI

6 days ago

Benchling is aggressively advancing its AI-driven biotech R&D platform, evidenced by multiple recent product launches including 'memory in Benchling AI,' 'Science Foundries' for AI agent teams, and 'BenchBench-Refusals' as an AI benchmark. A strategic partnership with NVIDIA for agentic lab infrastructure and a new customer win for Science Foundries further solidify its position as a leader in AI-powered scientific innovation and data management.

Signal Types

Product Launch Partnership Customer Acquisition Hiring Media Coverage Event Participation

Strategic Labels

AI Innovation Platform Expansion Strategic Partnerships

Next Move: Expansion

Impact: 9/10

Ideal For: AI/Biotech SaaS VCs — Growth Stage

About Benchling

Benchling, founded in 2012, is at the forefront of transforming the biotechnology and life sciences sectors. Headquartered in the United States, this innovative platform is redefining biotech R&D for the AI era with a mission to unlock the power of biotechnology, enabling global customers to reach milestones faster.

The company's platform serves as an AI-driven solution that integrates seamlessly into research workflows, allowing scientists to design experiments, capture structured data, and operate AI agents and models. Its impact is significant, with over 200,000 scientists from academic labs to major players like Sanofi and Moderna relying on Benchling.

Benchling's recent funding achievements include a substantial $100.00M Series F investment on 1 November 2021, backed by prominent investors Lone Pine Capital, Altimeter Capital, Franklin Templeton, and Tiger Global. Such backing underscores the platform's promise in reshaping the future of biotech R&D through data-driven and AI-enhanced solutions.

Business keywords: R&D Acceleration, Scientific Data Management, Life Sciences Software, Experiment Design, Biopharma Research, Cloud Applications, CRISPR, CAR-T Immunotherapy, Genetic Engineering, AI-Powered Research, Workflow Automation, Biotech Innovation, Data-Driven Science

Services & Products

Predictive Models Connection

Experiment Design and Analysis

Data Management and Capture

Workflow Automation

Software and AI Integration

Custom App Development

Scientific Data Modeling

Target Customers

Scientists Biopharma Companies Research Teams R&D Departments Industrial Biotech Firms Agritech Innovators Academic Institutions

Pricing

as listed on Sep 29, 2026

On request

Benchling's pricing page

Funding Rounds & Investors (9)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Series F	$100.00M	4	Lone Pine Capital, Altimeter Capital +2	01 Nov 2021
Series E	$200.00M	12	Lux Capital, Benchmark +10	01 Apr 2021
Series D	$50.00M	2	Alkeon Capital, Iconiq Growth	01 May 2020
Series C	$34.50M	5	Y Combinator, Benchmark +3	01 Jul 2019
Series B	$14.50M	3	Benchmark, F-Prime Capital +1	01 Jun 2018
Series A	$7.00M	1	Thrive Capital	01 Oct 2016
Seed	$5.00M	3	Andreessen Horowitz/ a16z, Thrive Capital +1	01 Apr 2015
Seed	$130.00K	1	Y Combinator	01 Sep 2014
Support Program	Undisclosed	1	Y Combinator	01 Jul 2012

Latest News

View All

Benchling - 2026 Funding Rounds & List of Investors

Tracxn Oct 30, 2026

Benchling brings goal-driven AI agent teams to the lab with Science Foundries

R&D World Oct 15, 2026

Benchling launches Science Foundries, a new way for scientists and agents to work together

PR Newswire Oct 15, 2026

Benchling launches Direct Data Share, Closing the Loop Between the Lab and the AI Data Cloud on Snowflake

Yahoo Finance Oct 15, 2026

Sanofi forms cloud partnership with Benchling

Tech Jun 12, 2024

Reshape wants to help ‘decode nature’ by automating the ‘visual’ part of lab experiments

Techcrunch Apr 09, 2024

Benchling Alternatives & Competitors

View All Alternatives

Benchling vs

Automata United Kingdom

Where legacy ends, Automata begins.

Series C

167 employees

AI, Biotechnology

Compare Benchling vs Automata

Benchling vs

Synthace United Kingdom

Helping scientists solve the world's most pressing problems with faster, more powerful experiments.

Series C

31 employees

Automation, Biotechnology

Compare Benchling vs Synthace

Benchling vs

Dianox Denmark

Scientific innovation that empowers researchers ✨

Non Equity Assistance

12 employees

AI, Biotechnology

View all alternatives

FAQ About Benchling

On a mission to unlock the power of biotechnology and empower our global customers to get to milestones & market faster.

Benchling was founded in 2012.

Benchling is headquartered in San Francisco, United States. As of Nov 2026, it also has offices in Boston, United States, Zurich, Switzerland and Belfast, United Kingdom.

Benchling operates in Biotechnology and Life Sciences. Its work centres on R&D Acceleration, Scientific Data Management, Life Sciences Software and Experiment Design. Its customers include Scientists, Biopharma Companies and Research Teams.

Benchling has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Usage Based and Service Fee.

As listed on Benchling's pricing page on Sep 29, 2026: On request.

Benchling has approximately 813 employees.

Benchling has completed 9 funding rounds, raising a total of $411.13M. The latest funding stage is Series F+.

Benchling offers: Predictive Models Connection, Experiment Design and Analysis, Data Management and Capture, Workflow Automation, Software and AI Integration, Custom App Development, Scientific Data Modeling.

Top alternatives and competitors to Benchling include Automata, Synthace, Dianox, LabFellows, Sandwalk BioVentures. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Benchling and Automata are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Benchling, https://www.bouncewatch.com/company/benchling, updated 8 November 2026. When citing, please name BounceWatch and link this page.

Benchling

General Information

Discover More

What changed at Benchling recently?

AI Insight

About Benchling

Services & Products

Target Customers

Pricing

Funding Rounds & Investors (9)

Latest News

Benchling Alternatives & Competitors

FAQ About Benchling